Search
for
Sort by
Research 301–330 of 1000+
- Chapter 23. Therapeutic Control of Androgen Action
- Caring for women with polycystic ovary syndrome
- Management of transgender patients in critical care
- Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome
- Evaluation of Androgen Receptor Expression and Its Association with Clinicopathological Features in Iraqi Women with Breast Cancer
- Synthesis and 5α-Reductase Inhibitory Activity of C21 Steroids Having 1,4-diene or 4,6-diene 20-ones and 4-Azasteroid 20-Oximes
- Visualising Androgen Receptor Activity in Male and Female Mice
- Minoxidil induced hypertrichosis in children
- Dermatological concerns for women and girls with turner syndrome
- Feminizing Adrenocortical Carcinoma Without Gynecomastia
- A recently characterized, underdiagnosed cause of female androgenetic alopecia and polycystic ovarian syndrome: non-classical 21 hydroxylase deficiency
- Rare Conditions of Hyperandrogenism Through Lifespan: A Case Series
- Virilisation in a young woman: A case demonstrating the importance of co-located mental and primary healthcare
- HAIR COAT AND STEROIDAL IMPLANT EFFECTS ON STEERS GRA ZING NDOPHYTE-INFECTED TALL FESCUE DURING THE SUMMER
- Laparoscopic adrenalectomy – a cure for male pattern baldness
- Pharmacological basis for clinical use of antiandrogens
- The profile of steroid hormones in human fetal and adult ovaries
- On the effects of testosterone on brain behavioral functions
- European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
- Recurrent implantation failure: A comprehensive summary from etiology to treatment
- Discovery and Clinical Development of Dutasteride, a Potent Dual 5α- Reductase Inhibitor
- Clinical biochemistry of dihydrotestosterone
- Steroid 17β-hydroxysteroid dehydrogenase deficiency in man: An inherited form of male pseudohermaphroditism
- A systematic review of antiandrogens and feminization in transgender women
- Unraveling the complex role of MAPT-containing H1 and H2 haplotypes in neurodegenerative diseases
- Testosterone Induces Increase in Aquaporin (AQP)-1, 5, and 7 Expressions in the Uteri of Ovariectomized Rats
- Managing Cutaneous Manifestations of Hyperandrogenic Disorders
- Serum anti-Müllerian hormone: A potential biomarker for polycystic ovary syndrome
- Baicalin inhibits recruitment of GATA1 to the HSD3B2 promoter and reverses hyperandrogenism of PCOS
- Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia